SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRotork Regulatory News (ROR)

Share Price Information for Rotork (ROR)

Share Price is delayed by 15 minutes
Get Live Data
305.60    2.00 (0.66%)
Bid:
305.40
Ask:
306.00
Spread: 0.60 (0.196%)
Market Cap: £2.49b
ROR Live PriceLast checked at - London Stock Exchange

Intraday Rotork Share Chart

Share Buy-Back Programme

27 Jun 2024 18:01

RNS Number : 2414U
Rotork PLC
27 June 2024
 

 

Rotork plc

Share buy-back programme - Tranche 3

27 June 2024

 

As announced at the preliminary results on 5 March 2024, Rotork plc ('Rotork' or the 'Company') commenced a share buyback programme (the 'Programme') to repurchase ordinary shares of 0.5 pence each in the capital of the Company ('Ordinary Shares') of up to £50 million (excluding stamp duty and expenses). Our financial flexibility enables us to pursue strategic investments and we remain active in looking for suitable opportunities, consistent with our Growth+ strategy.

 

The third tranche will be carried out through an irrevocable non-discretionary agreement with Morgan Stanley & Co. International Plc ('MS'), pursuant to which MS shall purchase Ordinary Shares as riskless principal (and not as agent of Rotork) for the subsequent sale on to, and purchase by, Rotork. The third tranche of the Programme will commence on the later of 8 July 2024 and the day following the completion of the second tranche and end no later than 6 September 2024. The aggregate purchase price of all Ordinary Shares acquired under the third tranche of the Programme will be no greater than £10 million (excluding stamp duty and expenses). Any purchases under the Programme will take place in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase Ordinary Shares granted by its shareholders at the Company's 2024 Annual General Meeting (the '2024 Authority'). The maximum number of Ordinary Shares that the Company is authorised to purchase under the 2024 Authority is 86,125,908 Ordinary Shares. MS will make its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. Any Ordinary Shares purchased by the Company will be cancelled.

 

Any purchase of Ordinary Shares in relation to the Programme will be carried out on the London Stock Exchange and any other UK recognised investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with (and subject to limits prescribed by) the Company's 2024 Authority, Chapter 12 of the Financial Conduct Authority's Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). Rotork will announce any market repurchases of Ordinary Shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred.

 

Enquiries to:

 

Nick Hasell/Susanne Yule, FTI Consulting

Tel: +44 (0)20 3727 1340

Andrew Carter, Investor Relations Director, Rotork Plc

Tel: +44 (0) 1225 733 200

 

Legal Entity Identifier: 213800AH5RZIHGWRJ718

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFERRTIDFIS
Date   Source Headline
2nd Nov 20182:10 pmRNSDirector/PDMR Shareholding
2nd Nov 20182:10 pmRNSHolding(s) in Company
1st Nov 20181:45 pmRNSTotal Voting Rights
22nd Oct 20183:07 pmRNSDirector/PDMR Shareholding
1st Oct 201810:12 amRNSTotal Voting Rights
28th Sep 20189:11 amRNSDirector/PDMR Shareholding
24th Sep 20184:34 pmRNSDirector/PDMR Shareholding
23rd Aug 20182:35 pmRNSHolding(s) in Company
22nd Aug 20181:17 pmRNSDirector/PDMR Shareholding
20th Aug 20183:10 pmRNSHolding(s) in Company
9th Aug 20189:20 amRNSDirector Declaration
7th Aug 20187:00 amRNS2018 Half Year Results
2nd Aug 20185:21 pmRNSCompany Secretary Change
20th Jul 20182:51 pmRNSDirector/PDMR Shareholding
2nd Jul 201810:19 amRNSBlock listing Interim Review
2nd Jul 201810:18 amRNSTotal Voting Rights
22nd Jun 201812:10 pmRNSDirector/PDMR Shareholding
6th Jun 20183:26 pmRNSTotal Voting Rights
29th May 20189:51 amRNSDirector Declaration
21st May 20182:55 pmRNSDirector/PDMR Shareholding
11th May 20183:16 pmRNSHolding(s) in Company
8th May 201811:47 amRNSHolding(s) in Company
1st May 20185:33 pmRNSHolding(s) in Company
1st May 201810:49 amRNSTotal Voting Rights
27th Apr 20185:17 pmRNSDirector/PDMR Shareholding
27th Apr 20185:00 pmRNSDirector/PDMR Shareholding
27th Apr 20183:41 pmRNSResult of AGM
23rd Apr 20187:00 amRNSTrading Update
20th Apr 20184:36 pmRNSDirector/PDMR Shareholding
6th Apr 201810:01 amRNSHolding(s) in Company
3rd Apr 20189:24 amRNSTotal Voting Rights
26th Mar 201812:41 pmRNSDoc re. AGM Documents
22nd Mar 20184:22 pmRNSDirector/PDMR Shareholding
22nd Mar 20184:22 pmRNSDirector/PDMR Shareholding
22nd Mar 20184:21 pmRNSDirector/PDMR Shareholding
19th Mar 20184:48 pmRNSDirector/PDMR Shareholding
16th Mar 20183:42 pmRNSDirector/PDMR Shareholding
16th Mar 20183:39 pmRNSDirector/PDMR Shareholding
16th Mar 20183:38 pmRNSDirector/PDMR Shareholding
16th Mar 20183:36 pmRNSDirector/PDMR Shareholding
16th Mar 20183:35 pmRNSDirector/PDMR Shareholding
8th Mar 20185:23 pmRNSDirector/PDMR Shareholding
8th Mar 20185:21 pmRNSDirector/PDMR Shareholding
6th Mar 20187:00 amRNS2017 Full Year Results
2nd Mar 20188:27 amRNSTotal Voting Rights
23rd Feb 201811:40 amRNSDirector/PDMR Shareholding
23rd Feb 201811:39 amRNSDirector/PDMR Shareholding
23rd Feb 201811:38 amRNSDirector/PDMR Shareholding
1st Feb 20181:45 pmRNSTotal Voting Rights
19th Jan 20184:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.